133 results on '"Omura, Junichi"'
Search Results
2. Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database
3. Comparative Treatment Persistence and Adherence to Endothelin Receptor Antagonists Among Patients with Pulmonary Arterial Hypertension in Japan: A Real-World Administrative Claims Database Study
4. Correction: Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database
5. Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension
6. 17β-estradiol and estrogen receptor-α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin
7. PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
8. Abstract 15564: Transcriptional Profiling Unveils New Molecular Subgroups of Adaptive and Maladaptive Right Ventricular Remodeling in Pulmonary Hypertension
9. Real-world diagnostic landscape and incidence of pulmonary hypertension in adult congenital heart disease patients using administrative claims data in Japan.
10. Identification of Celastrol As a Novel Therapeutic Agent for Pulmonary Arterial Hypertension and Right Ventricular Failure Through Suppression of Bsg (Basigin)/CyPA (Cyclophilin A)
11. Different roles of myocardial ROCK1 and ROCK2 in cardiac dysfunction and postcapillary pulmonary hypertension in mice
12. Diagnostic and Prognostic Significance of Serum Levels of SeP (Selenoprotein P) in Patients With Pulmonary Hypertension
13. Abstract 17034: The AKT/AMPK/FOXO3 Axis in Pulmonary Arterial Hypertension
14. Abstract 16770: The Epigenetic Modifier EP300: A New Corner Stone in the Regulation of Both Vascular Remodeling and Right Ventricle Failure in Pulmonary Arterial Hypertension
15. Abstract 15621: Checkpoint Kinases Important Players in Lung Fibrogenesis and Pulmonary Vascular Remodeling: A Translational Study
16. Abstract 15259: Breast Cancer and Heritable Pah Due to Bmpr2 Mutation: An Unexpected Discovery
17. Abstract 13700: Role of Parp1-pkm2 Axis in the Pathogenesis of Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
18. Identification of Emetine as a Therapeutic Agent for Pulmonary Arterial Hypertension: Novel Effects of an Old Drug
19. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target
20. 17[beta]-estradiol and estrogen receptor a protect right ventricular function in pulmonary hypertension via BMPR2 and apelin
21. SmgGDS Prevents Thoracic Aortic Aneurysm Formation and Rupture by Phenotypic Preservation of Aortic Smooth Muscle Cells
22. Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease
23. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension: High-Throughput Screening of 5562 Compounds
24. Small GTP-Binding Protein GDP Dissociation Stimulator Prevents Thoracic Aortic Aneurysm Formation and Rupture by Phenotypic Preservation of Aortic Smooth Muscle Cells
25. Long-term dietary nitrite and nitrate deficiency causes the metabolic syndrome, endothelial dysfunction and cardiovascular death in mice
26. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target
27. Abstract 17806: Protective Roles of Small GTP-binding Protein GDP Dissociation Stimulator Against Angiotensin II-induced Thoracic Aortic Aneurysm Formation And Rupture in Mice -A Possible Novel Therapeutic Target
28. Abstract 16256: Identification of Emetine as a Novel Therapeutic Agent for Pulmonary Hypertension in Rats -High-Throughput Screening of 5,562 Compounds
29. Abstract 16146: Rivaroxaban Prevents the Development of Chronic Thromboembolic Pulmonary Hypertension in Mice - Novel Beneficial Effects of the FXa Inhibitor
30. Abstract 16134: Different Roles of Myocardial ROCK1 and ROCK2 in Response to Chronic Pressure-Overload in Mice
31. Abstract 15047: Prognostic Impacts of Plasma Levels of Cyclophilin A in Patients With Heart Failure
32. Abstract 14863: ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure-A Possible Novel Therapeutic Target
33. Abstract 14825: Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension -A Possible Novel Therapeutic Target
34. Treatment pattern and clinical outcomes in portopulmonary hypertension: A database study in Japan.
35. Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension.
36. Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
37. Pulmonary arterial hypertension: New pathophysiological insights and emerging therapeutic targets.
38. O51-2 - Prognostic Impacts of Plasma Levels of Cyclophilin A in Patients with Heart Failure
39. YIA-BS1 - Different Roles of Myocardial ROCK1 and ROCK2 in Response to Chronic Pressure-Overload in Mice
40. SmgGDS as a Crucial Mediator of the Inhibitory Effects of Statins on Cardiac Hypertrophy and Fibrosis: Novel Mechanism of the Pleiotropic Effects of Statins.
41. ROCK1 Plays a Crucial Role to Maintain Cardiac Function in Response to Pressure-Overload in Mice
42. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure-Overload in Mice
43. Basigin Mediates Pulmonary Hypertension by Promoting Inflammation and Vascular Smooth Muscle Cell Proliferation.
44. Crucial Role of Rho-kinase in Pressure-overload-induced Right Ventricular Hypertrophy and Dysfunction in Mice
45. Anthracycline-induced Cardiomyopathy with End-stage Renal Disease
46. Pheochromocytoma Presenting as Fulminant Cardiogenic Shock following Maltiple Organ Failure
47. Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach.
48. Right ventricular and pulmonary vascular changes in pulmonary hypertension associated with left heart disease.
49. Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension.
50. Abstract 13222: Cardiopulmonary Best Abstract Award: Long Noncoding RNA H19 in the Pathogenesis of Right Ventricular Failure Associated With Pulmonary Arterial Hypertension -A Putative Novel Biomarker and Therapeutic Target.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.